Strata Critical Medical Inc (SRTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,307 | -56,076 | -27,260 | -39,280 | -40,052 |
| Depreciation Amortization | 5,962 | 7,111 | 5,725 | 1,313 | 596 |
| Income taxes - deferred | -255 | -1,466 | -772 | -3,752 | -3,643 |
| Accounts receivable | -998 | -10,254 | -5,347 | -2,197 | -414 |
| Other Working Capital | -3,021 | -6,691 | -17 | -1,617 | -2,199 |
| Other Operating Activity | 23,100 | 35,027 | -9,459 | 23,902 | 30,097 |
| Operating Cash Flow | $-2,519 | $-32,349 | $-37,130 | $-21,631 | $-15,615 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -143,255 | -245,438 | 30,361 | -280,263 | -297,472 |
| PPE Investments | -30,862 | -1,971 | -730 | -521 | -297 |
| Net Acquisitions | -2,230 | N/A | -48,101 | -23,065 | -23,065 |
| Purchase Of Investment | 177,450 | 264,498 | 97,810 | N/A | N/A |
| Purchase Sale Intangibles | -2,119 | 0 | N/A | -12,357 | N/A |
| Other Investing Activity | -2,119 | 0 | 0 | -12,861 | -504 |
| Investing Cash Flow | $-1,016 | $17,089 | $79,340 | $-316,710 | $-321,338 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -1,165 | -1,165 |
| Common Stock Issued | 168 | 70 | 87 | 119,939 | 119,778 |
| Common Stock Repurchased | -244 | 0 | N/A | N/A | N/A |
| Other Financing Activity | -5,683 | -146 | -1,171 | 210,525 | 213,646 |
| Financing Cash Flow | $-5,759 | $-76 | $-1,084 | $329,299 | $332,259 |
| Exchange Rate Effect | -80 | -66 | 72 | -9 | N/A |
| Beginning Cash Position | 29,021 | 44,423 | 3,225 | 19,858 | 12,276 |
| End Cash Position | 19,647 | 29,021 | 44,423 | 10,807 | 7,582 |
| Net Cash Flow | $-9,374 | $-15,402 | $41,198 | $-9,051 | $-4,694 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,519 | -32,349 | -37,130 | -21,631 | -15,615 |
| Capital Expenditure | -30,875 | -2,109 | -730 | -521 | -297 |
| Free Cash Flow | -33,394 | -34,458 | -37,860 | -22,152 | -15,912 |